Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26217517 | 0.76 | YTHDC1 (0.56) | P2RY1YTHDC1 | |
| SCHEMBL690985 | 0.75 | P2RY1 (0.68) | P2RY1YTHDC1 | |
| SCHEMBL30513029 | 0.75 | P2RY1 (0.68) | P2RY1YTHDC1 | |
| SCHEMBL29427723 | 0.72 | P2RY1 (0.56) | P2RY1YTHDC1 | |
| SCHEMBL31425733 | 0.70 | P2RY1 (0.53) | P2RY1YTHDC1 | |
| SCHEMBL20774171 | 0.66 | P2RX7 (0.49) | P2RY1YTHDC1 | |
| SCHEMBL9584187 | 0.66 | P2RY1 (0.50) | P2RY1YTHDC1 | |
| SCHEMBL26224198 | 0.65 | YTHDC1 (0.56) | P2RY1YTHDC1 | |
| SCHEMBL19633358 | 0.65 | CDK1 (0.52) | P2RY1YTHDC1 | |
| SCHEMBL19575375 | 0.64 | YTHDC1 (0.43) | P2RY1YTHDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100183598-A1 | METHODS OF TREATING CARDIOVASCULAR DISORDERS | CAROLUS THERAPEUTICS, INC. (US) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100183598-A1 | METHODS OF TREATING CARDIOVASCULAR DISORDERS | TNNI3, TNNT2, FABP3 | P2RY1 352/4885YTHDC1 1722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.